NIRVF (Nirvana Life Sciences) Other Current Receivables: $0.01 Mil (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nirvana Life Sciences Other Current Receivables?

Nirvana Life Sciences NIRVF Other Current Receivables is $0.01 Mil as of Jan. 2026. The stock has 3 warning signs investors should review.

Nirvana Life Sciences's Other Current Receivables for the quarter that ended in Jan. 2026 was $0.01 Mil.

Nirvana Life Sciences's quarterly Other Current Receivables increased from Jul. 2025 ($0.01 Mil) to Oct. 2025 ($0.01 Mil) but then stayed the same from Oct. 2025 ($0.01 Mil) to Jan. 2026 ($0.01 Mil).

Nirvana Life Sciences's annual Other Current Receivables increased from Apr. 2023 ($0.01 Mil) to Apr. 2024 ($0.01 Mil) but then declined from Apr. 2024 ($0.01 Mil) to Apr. 2025 ($0.01 Mil).

Nirvana Life Sciences Other Current Receivables Related Terms

Nirvana Life Sciences Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Nirvana Life Sciences's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nirvana Life Sciences Other Current Receivables Chart

Nirvana Life Sciences Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Apr22 Apr23 Apr24 Apr25
Other Current Receivables
Get a 7-Day Free Trial 0.01 0.01 0.01 0.01 0.01

Nirvana Life Sciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Nirvana Life Sciences Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.01 Mil mean?
Nirvana Life Sciences (NIRVF) has a Other Current Receivables of $0.01 Mil as of Jan. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Nirvana Life Sciences and its competitors.
Is Nirvana Life Sciences' Other Current Receivables too high?
Nirvana Life Sciences' current Other Current Receivables is $0.01 Mil.
How does Nirvana Life Sciences' Other Current Receivables compare to VRTX and REGN?
Nirvana Life Sciences' Other Current Receivables of $0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Nirvana Life Sciences and its competitors. Nirvana Life Sciences's current Other Current Receivables is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nirvana Life Sciences stock overvalued right now?
Nirvana Life Sciences (NIRVF) has a current Other Current Receivables of $0.01 Mil. The current Other Current Receivables is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Nirvana Life Sciences (NIRVF), the current Other Current Receivables is $0.01 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nirvana Life Sciences Business Description

Other Exchanges NIRV.X:Canada
Address 650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of therapeutic products derived from psychedelics. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.